FDA’s Plan B Ruling Doesn’t End Battle for Access
Women had reason to celebrate when the FDA ruled the morning-after-pill could be sold to women ages 18 and up. Now, Annie Tummino says she and others are continuing to battle the FDA to end all age and access restrictions to the contraceptive.
